A Surprising Pharma Giant is Set to Surge — Here’s Why Investors Are Buzzing
Novo Nordisk A/S stands out as a resilient investment choice amid economic uncertainty, focusing on diabetes and obesity treatments. Recent expansions, including acquisitions of Catalent sites, enhance its manufacturing capabilities,…